Rates of glaucoma medication utilization among older adults with suspected glaucoma, 1992 to 2002.
Rates of glaucoma medication utilization among older adults with suspected glaucoma, 1992 to 2002.
复制标题
1992 年至 2002 年疑似青光眼老年人的青光眼药物使用率。
DOI：
10.1016/j.ajo.2006.12.025
复制
发表时间：
2007
影响因子：
4.2
通讯作者：
Lee,PaulP
中科院分区：
文献类型：
--
作者：
Stein,JoshuaD;Sloan,FrankA;Lee,PaulP
目的：在医疗保险当前受益调查（MCBS）中确定青光眼嫌疑人的青光眼药物利用率，并确定各种治疗药物类别的近期利用模式。方法：通过使用1992年至2002年的MCBS数据与医疗保险索赔数据合并，计算调查参与者≥65岁疑似青光眼的青光眼药物类别利用率。在11年期间的使用趋势被确定。每年，超过85%的青光眼嫌疑人没有使用任何药物。在1992年和2002年之间，β受体阻滞剂和缩瞳剂的使用率大幅下降，α受体激动剂，组合β受体阻滞剂-碳酸酐酶抑制剂，前列腺素analogues. CONCLUSION本研究确定了最近的变化模式的青光眼嫌疑人使用的药物通过使用患者报告的信息，从而避免依赖于第三方数据库。随着时间的推移，这种趋势是重要的认识，因为它们反映了病人护理的变化，并具有经济和临床意义。
PURPOSETo determine rates of glaucoma medication utilization among glaucoma suspects in the Medicare Current Beneficiary Survey (MCBS) and identify recent utilization patterns for various hypotensive drug classes.DESIGNCohort study.METHODSBy using MCBS data between 1992 and 2002 merged with Medicare claims data, utilization rates for glaucoma medication classes were calculated for survey participants ≥65 years with suspected glaucoma. Utilization trends over the 11-year period were identified.RESULTSEach year, more than 85% of glaucoma suspects used no hypotensive medications. Between 1992 and 2002, utilization rates decreased substantially for β-blockers and miotics and increased for α-agonists, combination β-blockers–carbonic-anhydrase inhibitors, and prostaglandin analogues.CONCLUSIONThis study identifies recent changes in patterns of glaucoma suspects’ use of hypotensive medications by using patient-reported information, thus avoiding reliance on third-party databases. Such trends over time are important to recognize, because they reflect variations in patient care and have economic and clinical implications.